Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma

NCT03108677 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT03108677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03108677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2017
Completion date
December 30, 2023
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung metastases, osteosarcoma